{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:00:26Z","timestamp":1792188026814,"version":"4.4.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1704,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1365-2133.2010.10160.x","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T14:54:47Z","timestamp":1291388087000},"page":"no-no","source":"Crossref","is-referenced-by-count":25,"title":["Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership"],"prefix":"10.1093","author":[{"given":"V.","family":"Eleftheriadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Corne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ersser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the vitiligo priority setting partnership","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.113.1.47","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-4362.2000.00880.x","article-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","volume":"39","author":"Boisseau-Garsaud","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.239.12.1183","article-title":"Vitiligo. What is it? Is it important?","volume":"239","author":"Lerner","year":"1978","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB4|cit4","first-page":"493","article-title":"Response to cosmetic disfigurement: patients with vitiligo","volume":"39","author":"Porter","year":"1987","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archderm.114.9.1384","article-title":"Personal responses of patients to vitiligo: the importance of the patient-physician interaction","volume":"114","author":"Porter","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","article-title":"Psychological reaction to chronic skin disorders: a study of patients with vitiligo","volume":"1","author":"Porter","year":"1979","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000275657","article-title":"Clinical features and treatment outcomes of vitiligo from the patients\u2019 perspective: results of a national survey in Germany","volume":"220","author":"Radtke","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB9|cit9","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.328.7438.475","article-title":"Well informed uncertainties about the effects of treatments","volume":"328","author":"Chalmers","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB11|cit11","volume-title":"The James Lind Alliance Guidebook","author":"James Lind Alliance","year":"2010"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/nau.20816","article-title":"Prioritizing research: patients, carers, and clinicians working together to identify and prioritize important clinical uncertainties in urinary incontinence","volume":"29","author":"Buckley","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB13|cit13","unstructured":"NHS Evidence UK Database of Uncertainties About the Effects of Treatments (DUETs) http:\/\/www.library.nhs.uk\/DUETs\/Default.aspx"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/09638230600731586","article-title":"Identifying uncertainties about the effects of treatments for schizophrenia","volume":"15","author":"Lloyd","year":"2006","journal-title":"J Ment Health"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB16|cit16","first-page":"56","article-title":"Have your say in research into vitiligo","volume":"8","author":"Eleftheriadou","year":"2009","journal-title":"Dermatolog Nurs"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB17|cit17","first-page":"1","article-title":"Have your say in research into vitiligo (advertisement)","volume":"9","author":"Eleftheriadou","year":"2009","journal-title":"Bull Prim Care Dermatol Soc"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2753.2009.01262.x","article-title":"Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions","volume":"16","author":"Elwyn","year":"2010","journal-title":"J Eval Clin Pract"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: the pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2010.10160.x-BIB21|cit21","unstructured":"NHS INVOLVE: National Institute for Health Research http:\/\/www.invo.org.uk\/"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10160.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10160.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T19:02:14Z","timestamp":1711998134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/3\/530\/6643922"}},"subtitle":["Results of the vitiligo priority setting partnership"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10160.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}